These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8433071)

  • 1. Moclobemide overdose.
    Myrenfors PG; Eriksson T; Sandsted CS; Sjöberg G
    J Intern Med; 1993 Feb; 233(2):113-5. PubMed ID: 8433071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of moclobemide taken in overdose for attempted suicide.
    Hetzel W
    Psychopharmacology (Berl); 1992; 106 Suppl():S127-9. PubMed ID: 1546127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three suicide attempts with moclobemide.
    Iwersen S; Schmoldt A
    J Toxicol Clin Toxicol; 1996; 34(2):223-5. PubMed ID: 8618258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin syndrome caused by overdose with paroxetine and moclobemide.
    FitzSimmons CR; Metha S
    J Accid Emerg Med; 1999 Jul; 16(4):293-5. PubMed ID: 10417944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Poisoning with a reversible and selective monoaminooxidase inhibitor].
    Pall M; Bested KM; Eriksen ND
    Ugeskr Laeger; 1997 Aug; 159(32):4859-60. PubMed ID: 9273760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin syndrome due to an overdose of moclobemide and clomipramine. A potentially life-threatening association.
    François B; Marquet P; Desachy A; Roustan J; Lachatre G; Gastinne H
    Intensive Care Med; 1997 Jan; 23(1):122-4. PubMed ID: 9037653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Five fatal cases of serotonin syndrome after moclobemide-citalopram or moclobemide-clomipramine overdoses.
    Neuvonen PJ; Pohjola-Sintonen S; Tacke U; Vuori E
    Lancet; 1993 Dec; 342(8884):1419. PubMed ID: 7901695
    [No Abstract]   [Full Text] [Related]  

  • 8. Fatal serotonin syndrome caused by moclobemide-clomipramine overdose.
    Ferrer-Dufol A; Perez-Aradros C; Murillo EC; Marques-Alamo JM
    J Toxicol Clin Toxicol; 1998; 36(1-2):31-2. PubMed ID: 9541038
    [No Abstract]   [Full Text] [Related]  

  • 9. Fatal serotonin syndrome following a combined overdose of moclobemide, clomipramine and fluoxetine.
    Power BM; Pinder M; Hackett LP; Ilett KF
    Anaesth Intensive Care; 1995 Aug; 23(4):499-502. PubMed ID: 7485947
    [No Abstract]   [Full Text] [Related]  

  • 10. Overdose with moclobemide.
    Heinze G; Sanchez A
    J Clin Psychiatry; 1986 Aug; 47(8):438. PubMed ID: 3733681
    [No Abstract]   [Full Text] [Related]  

  • 11. [Moclobemide poisoning].
    Sadeg N; Deschamps P; Dumontet M
    Therapie; 1995; 50(5):488-9. PubMed ID: 8571301
    [No Abstract]   [Full Text] [Related]  

  • 12. Fatal moclobemide overdose or death caused by serotonin syndrome?
    Hernandez AF; Montero MN; Pla A; Villanueva E
    J Forensic Sci; 1995 Jan; 40(1):128-30. PubMed ID: 7876795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An uncommon fatality due to moclobemide and paroxetine.
    Singer PP; Jones GR
    J Anal Toxicol; 1997 Oct; 21(6):518-20. PubMed ID: 9323537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suicide with moclobemide and perazine.
    Musshoff F; Varchmin-Schultheiss K; Madea B
    Int J Legal Med; 1998; 111(4):196-8. PubMed ID: 9646163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of moclobemide in clinical use.
    Chen DT; Ruch R
    Clin Neuropharmacol; 1993; 16 Suppl 2():S63-8. PubMed ID: 8313399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical overview on moclobemide.
    Tiller JW
    Prog Neuropsychopharmacol Biol Psychiatry; 1993 Sep; 17(5):703-12. PubMed ID: 8255982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Moclobemide: therapeutic use and clinical studies.
    Bonnet U
    CNS Drug Rev; 2003; 9(1):97-140. PubMed ID: 12595913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moclobemide fatalities: report of two cases and analytical determinations by GC-MS and HPLC-PDA after solid-phase extraction.
    Gaillard Y; Pépin G
    Forensic Sci Int; 1997 Jun; 87(3):239-48. PubMed ID: 9248042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A risk-benefit assessment of moclobemide in the treatment of depressive disorders.
    Norman TR; Burrows GD
    Drug Saf; 1995 Jan; 12(1):46-54. PubMed ID: 7741983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fatal form of serotonin syndrome].
    Finge T; Malavialle C; Lambert J
    Ann Fr Anesth Reanim; 1997; 16(1):80-1. PubMed ID: 9686110
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.